Cargando…
Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
A large number of genes are altered in cancer cells. Often, reversal or inhibition of just one of these alterations leads to death of the cancer cells. Technological advances in multiple areas are necessary to potentiate clinical translation of these findings. In a recent article, Brock and colleagu...
Autores principales: | Teo, Wei Wen, Sukumar, Saraswati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053158/ https://www.ncbi.nlm.nih.gov/pubmed/25927933 http://dx.doi.org/10.1186/bcr3656 |
Ejemplares similares
-
BRCA1: linking HOX to breast cancer suppression
por: Jin, Kideok, et al.
Publicado: (2010) -
Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer
por: Tran, Lesa A, et al.
Publicado: (2011) -
Distributed Ledger Technology in genomics: a call for Europe
por: Thiebes, Scott, et al.
Publicado: (2019) -
Toward Comprehensive Patient-Centric Care by Integrating Digital Health Technology With Direct Clinical Contact in Australia
por: Schofield, Penelope, et al.
Publicado: (2019) -
Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer—a preclinical study
por: Wang, Guannan, et al.
Publicado: (2022)